Company Announcements - Insight Molecular Diagnostics, or iMDx, will report its second quarter 2025 financial results after the market closes on August 11, 2025 [1] - A live Zoom webinar will be held on the same day at 2:00 pm PT / 5:00 pm ET to discuss the financial results, followed by a Q&A session [1] - An archived replay of the webinar will be available on iMDx's investor relations website after the call concludes [2] Upcoming Events - CEO Josh Riggs and CFO Andrea James will attend the 10th Annual Needham Virtual MedTech & Diagnostics Conference on August 12, 2025 [3] - The conference will take place virtually from August 11-12, 2025, and investors can book one-on-one meetings with management through their Needham sales representative [3][4] Company Background - Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corp., is focused on democratizing access to novel molecular diagnostic testing to improve patient outcomes [4] - The company moved its headquarters from Irvine, California, to Nashville, Tennessee, in June 2025, with a new NASDAQ symbol effective June 18 [5]

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham Virtual Healthcare Conference, taking place from April 7-10, 2025. In addition, CEO Josh Riggs will participate in a fireside chat at the conference. During the event, Josh and Andrea will discuss Oncocyte’s innovative diagnostic technologies and will high ...